Viridian Therapeutics stock slides on pricing stock offering to raise $150 million
Summary
None Viridian Therapeutics (NASDAQ:VRDN) announces the pricing of an underwritten public offering with gross proceeds of approximately $150.0 million. None The company is selling a total of 7.14 million shares of common stock at a public offering price of $21.00 per share. None In addition, Viridian has granted the underwriters a 30-day option to purchase an additional 1.07 million shares of common stock at the public offering price. None The offering is expected to close on or about January 22, 2024. None The company said it intends to use the proceeds from the proposed underwritten public offering of its shares of common stock, together with its cash, cash equivalents and short-term investments, to further its clinical development programs, as well as for working capital and general corporate purposes.